ABBV-553
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ABBV-553, covering 2017-11-06 to 2017-11-06. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ABBV-553 in Healthy Volunteers and in Subjects With Psoriasis and Efficacy of ABBV-553 in Subjects With Psoriasis [Phase 1]